China GLP-1 Receptor Agonist Market Analysis The China GLP-1 receptor agonist market was valued at USD 2.35 billion in 2025, supported by rapid emergence of domestic peptide drug developers, increasing government support for innovative biologics under national healthcare reforms, and expanding local manufacturing capacity for metabolic therapies
Alimentos contaminados podem causar uma srie de doenas, desde intoxicaes alimentares leves at graves surtos de doenas transmitidas por alimentos, que podem ser fatais
ChandlerPDChenWYAjalaONHazraACookNBubesVet al
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Consistency matters more than timing, since benefits build over time
The data we provide is highly reliable and, thanks to its international comparability and recognition, makes it easier for you to take the next steps towards a rapid market launch of your products